2021 Annual Meeting | General Neurology Posters

Date/Time This program spans the entire conference

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology

CME Available 0.00 credit

Program Tracks COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT	Abstract	001 - Modulation of cerebral arterial flow by anodic transcranial direct current electrical stimulation Edgar Botello-Hernandez
07:00 AM - 05:00 PM EDT	Abstract	002 - Utilization of Diagnostic Testing for COVID-19 Patients Suffering from Encephalopathy Puja Jain, MD
07:00 AM - 05:00 PM EDT	Abstract	003 - Cerebrospinal fluid interleukine-8 to distinguish Guillain-Barré Syndrome from chronic inflammatory demyelinating polyneuropathy Gautier Breville, MD
07:00 AM - 05:00 PM EDT	Abstract	004 - Electrophysiological And Magnetic Resonance Neurography Correlate Of Non Traumatic Common Peroneal Neuropathy Divya M. Radhakrishnan, MD, DM (Neurology)
07:00 AM - 05:00 PM EDT	Abstract	005 - Natural Language Processing Model to Extract Acute Abnormalities from CT Head Reports Victor M. Torres-Lopez, MA
07:00 AM - 05:00 PM EDT	Abstract	006 - Altered Brain in Carpal Tunnel Syndrome: A Meta-analysis of Structural and Functional Magnetic Resonance Imaging Mohamed Fahmy Doheim
07:00 AM - 05:00 PM EDT	Abstract	007 - HTT CAG Repeat Length Variation in Huntington Disease (HD) Patients: Experience from a US Reference Laboratory Sat Dev Batish, PhD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	008 - Infarct and Penumbra Growth Rate usage in Machine Learning Model Improves Prognostic Outcome Prediction in Acute Ischemic Stroke Srinivasa Rao Kundeti
07:00 AM - 05:00 PM EDT	Abstract	009 - Permanent Intrathecal Access in Domestic Piglet for Biomarker and Discovery Studies Megan G. Pino
07:00 AM - 05:00 PM EDT	Abstract	010 - KonectomTM Smartphone-based Digital Outcome Assessments for Adults Living with Spinal Muscular Atrophy (SMA): A Conceptual Framework Eduardo Arteaga Bracho
07:00 AM - 05:00 PM EDT	Abstract	011 - Neurological Manifestations of SARS-CoV-2 Infection in Type 2 Diabetes Parisorn Thepmankorn
07:00 AM - 05:00 PM EDT	Abstract	012 - Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke Carolina Gil Tommee, MD
07:00 AM - 05:00 PM EDT	Abstract	013 - Neurological Manifestations of Patients Hospitalized with COVID-19 Diagnosis at OLSU-S Junaid Ansari, MD
07:00 AM - 05:00 PM EDT	Abstract	014 - COVID-19 in patients with neurological disorders Carolina Gil Tommee, MD
07:00 AM - 05:00 PM EDT	Abstract	015 - Neurological biomarkers in COVID-19: Comparing patient biomarkers across hospital discharge status Cian Dabrowski, MS
07:00 AM - 05:00 PM EDT	Abstract	016 - Neurological Disorders associated with COVID-19 in Singapore Rebecca Hoe, MBBS, MRCP
07:00 AM - 05:00 PM EDT	Abstract	017 - Acute Encephalopathy in COVID-19 patients- Early Experience from an Inner-City Hospital Wan Yee Kong, MBBS
07:00 AM - 05:00 PM EDT	Abstract	018 - Long-Segment Peripheral Neuropathies after COVID-19: Magnetic Resonance Neurography Findings
07:00 AM - 05:00 PM EDT	Abstract	019 - Effect of Neurological Manifestations on SARS-CoV-2 Infection Prognosis using Machine Learning Models Parisorn Thepmankorn
07:00 AM - 05:00 PM EDT	Abstract	020 - COVID-19 in Patients With Pre-existing Neurologic Disorders: Clinical Course and Outcomes Svetlana Blitshteyn, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	021 - Effect Sizes of Vascular Risk Factors for Stroke Occurrence by Age Among West Africans Mayowa Owolabi, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	022 - Idiopathic Intracranial Hypertension in a Pregnant Female Improved with Venous Sinus Stenting Hera A. Kamdar, MD
07:00 AM - 05:00 PM EDT	Abstract	023 - Neurologic Manifestations in Polycythemia; A 5 Year Study from South India Vivek Bhat
07:00 AM - 05:00 PM EDT	Abstract	024 - Large Bilateral Hemorrhagic Infarctions Secondary to Cerebral Venous Sinus Thrombosis in a Patient with Focal Segmental Glomerulosclerosis: A Case Report Noelia C. Morales, MD
07:00 AM - 05:00 PM EDT	Abstract	025 - Widespread Infarction: When a Spinal Cord Infarct Involves More than Just the Cord Venus Barlas
07:00 AM - 05:00 PM EDT	Abstract	026 - Prolonged reversible focal neurologic deficits in the elderly with contralateral EEG slowing: a post-ictal, migrainous, or vascular phenomenon? Kelsey M. Smith, MD
07:00 AM - 05:00 PM EDT	Abstract	027 - Hereditary hemorrhagic telangiectasia and pulmonary and cerebral complications: A case report and literature review Ah Ryung Lim
07:00 AM - 05:00 PM EDT	Abstract	028 - Calf claudication secondary to normal pressure hydrocephalus, a case report David E. Kvarnberg, MD
07:00 AM - 05:00 PM EDT	Abstract	029 - Eclampsia Resulting in Posterior Reversible Encephalopathy Syndrome with Spinal Cord and Optic Nerve Involvement Negar Moheb, MD
07:00 AM - 05:00 PM EDT	Abstract	030 - The Virtual Neurologic Exam: Instructional Videos and Guidance for the COVID-19 Era Mariam a. Al Hussona, MB BCh BAO
07:00 AM - 05:00 PM EDT	Abstract	031 - Patients and Providers Satisfaction with Telemedicine at the Beginning of the COVID 19 Pandemic- A Neurology Department Experience Omar M. Said
07:00 AM - 05:00 PM EDT	Abstract	032 - Teleneurology As a Tool to Increase Patient Visit Compliance During the COVID-19 Pandemic Shayan Torabi Moghaddam, DO
07:00 AM - 05:00 PM EDT	Abstract	033 - Implementation and Evaluation of a Teleneurology Clinic Serving Vulnerable Populations in Zambia During the COVID-19 Pandemic Melody T. Asukile, MBBS
07:00 AM - 05:00 PM EDT	Abstract	034 - Evaluation of Patient Financial Savings from Telemedicine Implementation in a Neurology Department in a Major Urban Academic Medical Center Melissa Reider-Demer, DNP, MN, CNP
07:00 AM - 05:00 PM EDT	Abstract	035 - Evaluation of Patient and Clinician Perspectives for New and Return Ambulatory Teleneurology Visits, with special attention to subspecialty differences Jessica Falco-Walter, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	036 - Adapting the Neurology Resident Clinic Workflow in a Large Urban Hospital During the COVID-19 Pandemic: Did it Work? Nirav Sanghani, MBBS
07:00 AM - 05:00 PM EDT	Abstract	037 - How to build a residency training track for future Neurohospitalists: an AAN survey Jonathan Donnelly, MBBS
07:00 AM - 05:00 PM EDT	Abstract	038 - How Do Patients and Physicians Experience the Same Teleneurology Encounter? Sujata P. Thawani, MD
07:00 AM - 05:00 PM EDT	Abstract	039 - Resident-Based Patient Triage Improves Acuity of Outpatients in a Neurology Urgent Care Clinic Setting Micah Etter, MD
07:00 AM - 05:00 PM EDT	Abstract	040 - Outcomes of a QI/QA Project to Improve Hand-offs in an Urban Neurology Residency Program Osama M. Abu-hadid, MD
07:00 AM - 05:00 PM EDT	Abstract	041 - Newsworthiness of Neurological Research Isha Snehal, MBBS
07:00 AM - 05:00 PM EDT	Abstract	042 - Abstract: Fast Neuro - Expedited Access to Neurology Clinic Shuvro Roy, MD
07:00 AM - 05:00 PM EDT	Abstract	043 - A Value Assessment of Diagnostic Modalities for Trigeminal Sensory Neuropathy Sherri A. Braksick, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	044 - Clinical and Epidemiological Characteristics of Patients with TTR Mutations and Polyneuropathy Manifestations of Hereditary Transthyretin Amyloidosis: Insights from a Genetic Testing Program Sami L. Khella, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	045 - A Patient-Focused Survey to Assess the Effects of the COVID-19 Pandemic and Social Policies on People with Muscular Dystrophy Leann Lewis
07:00 AM - 05:00 PM EDT	Abstract	046 - Stroke and dementia, leading causes of neurological disability and death, potential for prevention Abolfazl Avan, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	047 - Dog Ownership or Therapy to Potentially Ameliorate Burden of Neurological Disease Catherine Boldig, DO
07:00 AM - 05:00 PM EDT	Abstract	048 - COVID19 Neurological Manifestations in the Veteran’s Community Leila Saadatpour, MD
07:00 AM - 05:00 PM EDT	Abstract	049 - Analysis of ALS Biospecimen Demand and Utilization of Samples for the National ALS Biorepository
07:00 AM - 05:00 PM EDT	Abstract	050 - Following the trail in multiple cranial neuropathy: a case series in a hospital in Bogotá, Colombia Habib Georges Moutran Barroso, MD
07:00 AM - 05:00 PM EDT	Abstract	051 - Disease Burden and Healthcare Utilization Among Patients with Acute Intermittent Porphyria Experiencing Chronic Neuropathy: Analyses from a National Healthcare Database Angelika Erwin
07:00 AM - 05:00 PM EDT	Abstract	052 - Can’t Move My Face Or Feel My Body: A COVID-19 Associated Guillain Barre variant. Batool A. Hussain, MD, MBBS
07:00 AM - 05:00 PM EDT	Abstract	053 - Myasthenia Gravis in a patient being treated with pembrolizumab in the absence of anti-acetylcholine receptor antibodies Gaurav Kiri
07:00 AM - 05:00 PM EDT	Abstract	054 - Utilizing Holistic strategies for improvement of quality of life of patients with Generalized Myasthenia Gravis. Nakul Katyal, MD
07:00 AM - 05:00 PM EDT	Abstract	055 - Brachial Plexopathy: A Rare Association With A Wasp Sting Saad Karim, MD
07:00 AM - 05:00 PM EDT	Abstract	056 - SARS-CoV-2 Associated Guillain-Barré Syndrome with Dysautonomia Sydney V. Palka, MD
07:00 AM - 05:00 PM EDT	Abstract	057 - Immunoglobulin-Responsive Posterior Interosseous Neuropathy: A Variant of Multifocal Motor Neuropathy? Michael Isfort, MD
07:00 AM - 05:00 PM EDT	Abstract	058 - Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a well-controlled diabetic patient without complications Gaurav Kiri
07:00 AM - 05:00 PM EDT	Abstract	059 - Guillain-Barre Syndrome preceded by SARS-CoV-2 Infection in Setting of L2-L4 Radiculopathy/Plexopathy Gaurav Kathuria, MD
07:00 AM - 05:00 PM EDT	Abstract	060 - Refractory Localization Related Epilepsy Secondary to Intracranial Arachnoid Cyst: A Case Report and an algorithmic approach for evaluation and management Shruthishree Sukumar
07:00 AM - 05:00 PM EDT	Abstract	061 - SARS-CoV-2 Presenting as Posterior Reversible Encephalopathy Syndrome (PRES) in Absence of Respiratory Symptoms. Paul Wilkerson, DO
07:00 AM - 05:00 PM EDT	Abstract	062 - A Pattern Analysis of Cerebral Metastasis Using FDG PET Imaging Guhan Ramamurthy, MD, DM
07:00 AM - 05:00 PM EDT	Abstract	063 - Sever hyperammonemic encephalopathy post sleeve gastrectomy Lubna E. El Sheikh, Jr., MBBS
07:00 AM - 05:00 PM EDT	Abstract	064 - A case of Delayed and Reversible Chemotherapy-Induced Leukoencephalopathy Junaid H. Siddiqui, MD
07:00 AM - 05:00 PM EDT	Abstract	065 - Wernicke Encephalopathy Secondary to Acute Gastrointestinal Pathology Igor Zilberman, MD
07:00 AM - 05:00 PM EDT	Abstract	066 - Acute Wernicke’s Encephalopathy after Hemorrhagic Shock in a Non-alcoholic Patient Maryum Shoukat, MD
07:00 AM - 05:00 PM EDT	Abstract	067 - The Red Herring that Mimicked a Chameleon Faizan Aslam, MBBS
07:00 AM - 05:00 PM EDT	Abstract	068 - A Pictorial Essay of Corpus Callosum Lakshmi N. Ranganathan, MD, PhD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	069 - Abnormal Enlargement of Virchow-Robin spaces resulting in Paresthesia and Weakness Jaspreet Johal, MD
07:00 AM - 05:00 PM EDT	Abstract	070 - Diagnosis and Management of a Sibling Pair With Hereditary Transthyretin Amyloidosis Associated With F44S (p.Phe64Ser) Transthyretin Variant: A Case Report Eugenie Girouard, MD
07:00 AM - 05:00 PM EDT	Abstract	071 - A Curious Case of Gabapentin-Induced Increased Urinary Frequency Mustafa Mohammed, MD, MBBS
07:00 AM - 05:00 PM EDT	Abstract	072 - SNORD118 negative Labrune syndrome Matheus Alves A. Silva, MD
07:00 AM - 05:00 PM EDT	Abstract	073 - Classification of ataxic gait by shallow classifiers
07:00 AM - 05:00 PM EDT	Abstract	074 - Gabapentin-Induced Myokymia: A Case Report Aimalohi Esechie, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	075 - Evaluation of New-Onset Seizures in a Safety-Net Hospital Emergency Department Fatima Zuberi, MD, BA
07:00 AM - 05:00 PM EDT	Abstract	076 - Bariatric Berberi; The Other Thiamine Deficiency Michael B. Beeler, DO
07:00 AM - 05:00 PM EDT	Abstract	077 - Irreversible Cerebellar Ataxia Following Treatment with 5-Fluorouracil Deborah Rose, MD
07:00 AM - 05:00 PM EDT	Abstract	078 - No Laughing Matter: A Case of Nitrous Oxide Toxicity and Factitious Disorder Han S. Lee
07:00 AM - 05:00 PM EDT	Abstract	079 - Transplanted patients and cerebrospinal fluid Carla F. Bolano Diaz, MD
07:00 AM - 05:00 PM EDT	Abstract	080 - A systematic review of behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate in real-world studies Bernhard Steinhoff
07:00 AM - 05:00 PM EDT	Abstract	081 - Chronic Methanol Toxicity Through Topical and Inhalational Routes Presenting as Vision Loss and Restricted Diffusion of the Optic Nerves on MRI: A Case Report and Literature Review Christianne Mojica
07:00 AM - 05:00 PM EDT	Abstract	082 - Intravenous Glucose without Thiamine is Associated with Increased Mortality in Hospitalized Patients with Acute Encephalopathy Daniel Zhou, MD
07:00 AM - 05:00 PM EDT	Abstract	083 - Vitamin B6 (pyridoxine) Toxicity and OTC Supplements Madhureeta Achari, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	084 - Supplemental Thiamine is not Associated with Mental Status Improvement in Patients Hospitalized with Acute Encephalopathy Daniel Zhou, MD
07:00 AM - 05:00 PM EDT	Abstract	085 - Neurological Risks and Benefits of Medical Cannabis Ase: A Cross-sectional Analysis of Health Care Professionals’ Knowledge Jessica Rice, MD
07:00 AM - 05:00 PM EDT	Abstract	086 - Serotonin Receptor Activity Profiles for Nine Commercialized Ergot Alkaloids Correspond to Known Risks of Fibrosis and Hallucinations Robert Fishman, MD
07:00 AM - 05:00 PM EDT	Abstract	087 - Examining Associations Between Cannabinoid Products and Fall Risk in Patients with Neurological Conditions: Multiple Sclerosis, Polyneuropathy, Parkinson’s Disease, and Stroke Janardan S. Sivapalan
07:00 AM - 05:00 PM EDT	Abstract	088 - A Cell-Penetrating Peptide (CPP) Did Not Decrease 150-kDa BoNT/A Toxin Adsorption to Surfaces or Increase Toxin Potency or Duration in a Prototype Formulation
07:00 AM - 05:00 PM EDT	Abstract	089 - Unusual, Stable Phenotype in Patient with Ser70Arg TTR Mutation on Diflunisal Therapy Sean Mooney, MB BCh BAO
07:00 AM - 05:00 PM EDT	Abstract	090 - Time to Event Milestones in Patients With Amyotrophic Lateral Sclerosis Treated With IV Edaravone: Results From a US Administrative Claims Analysis Melissa Hagan
07:00 AM - 05:00 PM EDT	Abstract	091 - The Use of Medical Cannabis in the Treatment Comorbid Anxiety and Depression Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
07:00 AM - 05:00 PM EDT	Abstract	093 - Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study Michael J. Polydefkis, MD, FAAN
07:00 AM - 05:00 PM EDT	Abstract	094 - Increase in Polyneuropathy Disability Stage Does Not Predict Neuropathic Progression in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy Receiving Inotersen: Results from the NEURO-TTR Study Aaron Yarlas, PhD
07:00 AM - 05:00 PM EDT	Abstract	095 - A Phase 1, Multicenter, Open Label, Single-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) Angela L. Genge, MD
07:00 AM - 05:00 PM EDT	Abstract	096 - Phase 1/2a, Double-blind, Placebo-controlled Study of Ropinirole Hydrochloride Remedy for ALS (ROPALS trial) Based On The iPSC Drug Repositioning Shinichi Takahashi, MD
07:00 AM - 05:00 PM EDT	Abstract	097 - Immune Checkpoint Inhibitor use in Patients with Pre-existing Neurological Autoimmune Diseases: A Case Series Andrew R. Snavely
07:00 AM - 05:00 PM EDT	Abstract	098 - Medical Cannabis in the Treatment of Neuropathy Paul B. Hart

Faculty Disclosures
	No disclosure on file
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Iram Zaman, DO, FAAN	Dr. Zaman has nothing to disclose.
Mariam H. Haider, BS	Mariam Haider has nothing to disclose.
Rebecca Hoe, MBBS, MRCP	Dr. Hoe has nothing to disclose.
John L. Berk	John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda has received research support from NIH.
Angela Paradis	Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Zainab Mohammed	Miss Mohammed has nothing to disclose.
Madhu S. Jasti, MD, FAAN	Dr. Jasti has nothing to disclose.
Pria Anand, MD	Dr. Anand has nothing to disclose.
Lauren H. Sansing, MD	Dr. Sansing has nothing to disclose.
Jessica Rice, MD	Dr. Rice has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Brett L. Cucchiara, MD	Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elseiver. Dr. Cucchiara has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Bayer. Dr. Cucchiara has received publishing royalties from a publication relating to health care.
Terese Gullo, MD	Miss Gullo has nothing to disclose.
Victor M. Torres-Lopez, MA	Mr. Torres-Lopez has nothing to disclose.
Vicente Villanueva	Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Angelini. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Vicente Villanueva has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Paladin. Vicente Villanueva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical.
Megan T. Donnelly, DO	Dr. Donnelly has received personal compensation for serving as an employee of Novant Health. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AndHealth. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Donnelly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Donnelly has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Donnelly has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Donnelly has a non-compensated relationship as a Communications Director with Southern Headache Society that is relevant to AAN interests or activities.
Fatima Zuberi, MD, BA	Fatima Zuberi has nothing to disclose.
Kayoko Saito	No disclosure on file
Hera A. Kamdar, MD	Dr. Kamdar has nothing to disclose.
Alrabi Tawil, MD, FAAN	Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Viktor Perovic, MD	Dr. Perovic has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Daniel S. Newman, MD	Dr. Newman has nothing to disclose.
Lance E. Steward, PhD	Dr. Steward has received personal compensation for serving as an employee of Allergan Aesthetics an AbbVie Company. Dr. Steward has received stock or an ownership interest from Allergan Aesthetics an AbbVie Company.
Henrik Klitgaard	Mr. Klitgaard has received personal compensation for serving as an employee of UCB Inc. Mr. Klitgaard has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB Inc.
Sabrina Sacconi, MD	Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMICUS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FULCRUM THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AXELYS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for OLOGY. The institution of Dr. Sacconi has received research support from Solve FSHD.
George C. Diaz, MD	Dr. Diaz has nothing to disclose.
Mihir Kakara, MD	Dr. Kakara has nothing to disclose.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Brian J. Villafuerte Trisolini, MD	Dr. Villafuerte Trisolini has nothing to disclose.
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Gaurav Kathuria, MD	Dr. Kathuria has nothing to disclose.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Jasmine Koh, MBBS	Dr. Koh has nothing to disclose.
Kelly Rich, MS, CGC	Ms. Rich has nothing to disclose.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Tu Nguyen, MD	Dr. Nguyen has nothing to disclose.
Micah Etter, MD	Dr. Etter has nothing to disclose.
Edgar Botello-Hernandez	Edgar Botello-Hernandez has nothing to disclose.
Anurag Sahoo, MD	Dr. Sahoo has nothing to disclose.
John Ko, PharmD, MS	Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Kevin Tan, MD, FAAN	Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Carlos Lara, MD	Dr. Lara has nothing to disclose.
Mary Reilly, MD, FRCP, FRCPI	The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA.
Naluca Mwendaweli, MMED	NALUCA MWENDAWELI has nothing to disclose.
Divya M. Radhakrishnan, MD, DM (Neurology)	The institution of Dr. Radhakrishnan has received research support from Indian Council of Medical Research, New Delhi, India. Dr. Radhakrishnan has received research support from International Parkinson's and Movement Disorders Society, Asian Oceanian Section .
Tian Ming Tu, MD	Dr. Tu has nothing to disclose.
Yihui Goh, MBBS	Dr. Goh has nothing to disclose.
Maitreyi Murthy, MD	Dr. Murthy has nothing to disclose.
Monica E. Maher, MD	Dr. Maher has nothing to disclose.
Farng-Yang Foo, MD	Dr. Foo has nothing to disclose.
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Deepti Chrusciel, MD	Dr. Chrusciel has nothing to disclose.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Igor Zilberman, MD	Dr. Zilberman has nothing to disclose.
Carl A. Gold, MD, FAAN	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
Justin A. Morrison	Mr. Morrison has nothing to disclose.
Lukman F. Owolabi, PhD, MSc, FWAPC, FMCP	Dr. Owolabi has nothing to disclose.
Alexandria Soto	Ms. Soto has nothing to disclose.
Myrna Cardiel, MD	Dr. Cardiel has nothing to disclose.
Eu Jene Choi, MD, PhD(c)	Dr. Choi has nothing to disclose.
Malgorzata Ciepielewska	Malgorzata Ciepielewska has received personal compensation for serving as an employee of Mitsubishi Tanable Pharma America, Inc..
Gaurav Kiri	Gaurav Kiri has nothing to disclose.
Charles Kassardjian, MD, FAAN	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Katy Eichinger, PhD, PT, DPT, NCS	Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Michaela Walker, MPH, CCRP	Miss Walker has nothing to disclose.
Barbara M. Carvalho	Miss Carvalho has nothing to disclose.
Elena Shanina, MD, FAAN	Dr. Shanina has nothing to disclose.
Andrew C. Hui, MBBS, FRCP	Dr. Hui has nothing to disclose.
Jaydeep M. Bhatt, MD	Dr. Bhatt has nothing to disclose.
Nirav Sanghani, MBBS	Dr. Sanghani has nothing to disclose.
Navya Joseph, MD	Dr. Joseph has nothing to disclose.
Shinichi Takahashi, MD	The institution of Dr. Takahashi has received research support from JSPS KAKENHI. The institution of Dr. Takahashi has received research support from Eisai Japan. The institution of Dr. Takahashi has received research support from Bayer Japan. The institution of Dr. Takahashi has received research support from Boehringer Ingelheim Japan.
Leann Lewis	Leann Lewis has nothing to disclose.
Michael J. Polydefkis, MD, FAAN	Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Guhan Ramamurthy, MD, DM	Dr. Ramamurthy has nothing to disclose.
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN	Dr. Kelley has nothing to disclose.
Karima Benameur, MD	Dr. Benameur has nothing to disclose.
Albert K. Akpalu, MD	Dr. Akpalu has nothing to disclose.
Sean Mooney, MB BCh BAO	Dr. Mooney has nothing to disclose.
Jaspreet Johal, MD	Dr. Johal has nothing to disclose.
Sen Sheng, MD	Dr. Sheng has nothing to disclose.
Susan Shin, MD	Dr. Shin has nothing to disclose.
Lorraine Chishimba, MBChB, MMED	Dr. Chishimba has nothing to disclose.
Patrick R. Burke, MD	Dr. Burke has nothing to disclose.
Anu Venkat, MD	The institution of an immediate family member of Dr. Venkat has received research support from National institute of Helath . The institution of an immediate family member of Dr. Venkat has received research support from New York City Council . An immediate family member of Dr. Venkat has received personal compensation in the range of $0-$499 for serving as a Study section Reviewer with Veterans Administration .
Steve Garafalo	Steve Garafalo has received personal compensation for serving as an employee of Biogen. Steve Garafalo has received stock or an ownership interest from Biogen.
Joseph I. Sirven, MD, FAAN	Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Aftab Ahmad, MD	Dr. Ahmad has nothing to disclose.
Ramiro G. Castro Apolo, MD	Dr. Castro Apolo has nothing to disclose.
Shanna Patterson, MD, FAAN	Dr. Patterson has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Paul B. Hart	Mr. Hart has nothing to disclose.
Ajay Garg	Ajay Garg has nothing to disclose.
Bhanu Gogia, MBBS	Dr. Gogia has nothing to disclose.
Alejandro Tobon, MD, FAAN	Dr. Tobon has nothing to disclose.
Carrie Landess, MD	Dr. Landess has received personal compensation for serving as an employee of Carrie Landess MD PA.
Hannah H. Zamore	Hannah Zamore has nothing to disclose.
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Puja Jain, MD	Dr. Jain has nothing to disclose.
Neil A. Busis, MD, FAAN	Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Mariam a. Al Hussona, MB BCh BAO	Dr. Al Hussona has nothing to disclose.
Ron S. Broide, PhD	Dr. Broide has received personal compensation for serving as an employee of Allergan Aesthetics / AbbVie.
Bernhard Steinhoff	Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $0-$499 for serving as a Consultant for B.Braun Melsungen. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precisis. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Bernhard Steinhoff has received research support from UCB. The institution of Bernhard Steinhoff has received research support from Eisai. The institution of Bernhard Steinhoff has received research support from SK LIfe Science.
Cassie N. Chan, MD	Dr. Chan has nothing to disclose.
Barry L. Menna, DO, FAAN	Dr. Menna has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Multiple companies. Dr. Menna has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Multiple companies.
Leila Saadatpour, MD	Dr. Saadatpour has nothing to disclose.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Sachin Kedar, MD, FAAN	Dr. Kedar has nothing to disclose.
Ismail M. Fahad, MBBS	Dr. Fahad has nothing to disclose.
Wei Ping Kay Ng, MD	Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca.
Gabriella Garcia, MD	Dr. Garcia has nothing to disclose.
Vivek Bhat	Mr. Bhat has nothing to disclose.
Christen L. Shoesmith, MD, BSc, FAAN	The institution of Dr. Shoesmith has received research support from AL-Pharma. The institution of Dr. Shoesmith has received research support from Mitsubishi Tanabe. The institution of Dr. Shoesmith has received research support from Cytokinetics. The institution of Dr. Shoesmith has received research support from Sanofi. The institution of Dr. Shoesmith has received research support from Neurosense. The institution of Dr. Shoesmith has received research support from Regeneron. Dr. Shoesmith has a non-compensated relationship as a Canadian ALS Research Consortium Chair with ALS Canada that is relevant to AAN interests or activities.
Felix Rosenow	No disclosure on file
Gautier Breville, MD	Dr. Breville has nothing to disclose.
Martin Valis, MD	Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Emre Aldinc	Emre Aldinc has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Emre Aldinc has stock in Alnylam Pharmaceuticals.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Mahsa Sadeghi, MD	Dr. Sadeghi has nothing to disclose.
Prakash Kumar, MD	No disclosure on file
Carla F. Bolano Diaz, MD	Dr. Bolano Diaz has nothing to disclose.
Michel Toledano, MD	Dr. Toledano has nothing to disclose.
Omar M. Said	Omar Said has nothing to disclose.
Akshay Vaishnaw	Akshay Vaishnaw, 22867 has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Akshay Vaishnaw, 22867 has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Editas Medicine. Akshay Vaishnaw, 22867 has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Scholar Rock. Akshay Vaishnaw, 22867 has received stock or an ownership interest from Alnylam Pharmaceuticals.
Kaeli Samson	No disclosure on file
Fred Sarfo	Fred Sarfo has nothing to disclose.
Madhureeta Achari, MD, FAAN	Dr. Achari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKinney-Taylor.
Vibhor Krishna	No disclosure on file
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Sami L. Khella, MD, FAAN	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Kishan Raj, MD	Dr. Raj has nothing to disclose.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Brien J. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma.
Anastasia McManus	Anastasia McManus has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Anastasia McManus has received stock or an ownership interest from Alnylam Pharmaceuticals.
Venus Barlas	Venus Barlas has nothing to disclose.
Sama Astani, MD	Dr. Astani has nothing to disclose.
M M Arun Shivaraman, NP, D M	Dr. Shivaraman has nothing to disclose.
Robert Fishman, MD	Dr. Fishman has nothing to disclose.
Vivian E. Drory, MD	Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
Jin Nakahara, MD, PhD, FAAN	Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Japan Society for the Promotion of Science.
Ah Ryung Lim	Miss Lim has nothing to disclose.
Raymond M. Rivera Vergara, MD	Dr. Rivera Vergara has nothing to disclose.
Carolina Gil Tommee, MD	Dr. Gil Tommee has nothing to disclose.
Eric R. Wong, DO	Dr. Wong has nothing to disclose.
Steven M. McKnight, MD	Steven M. McKnight has nothing to disclose.
Narenraj Arulprakash, MD	Dr. Arulprakash has nothing to disclose.
Jawahar Marimuthu, DM	Dr. Marimuthu has nothing to disclose.
Sat Dev Batish, PhD, FAAN	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Mitchell F. Brin, MD, FAAN	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Oldrich Vysata	No disclosure on file
Christoph Kleinschnitz, MD	Dr. Kleinschnitz has nothing to disclose.
Danny Samkutty, MD	Dr. Samkutty has nothing to disclose.
Nina H. Kim, MD	Dr. Kim has nothing to disclose.
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Timothy Lim	No disclosure on file
Michelle A. Farrar	Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Stanley Zimba, MBBS	Dr. Zimba has nothing to disclose.
Frighton B. Mutete, MBChB	Dr. Mutete has nothing to disclose.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Evolyra Therapeutics . Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. Dr. Johnson has stock in Evolyra Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. The institution of Dr. Johnson has received research support from Avidity Biosciences. The institution of Dr. Johnson has received research support from Edgewise. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Alex Baeta	Alex Baeta has nothing to disclose.
Navdeep Sangha, MD	Dr. Sangha has nothing to disclose.
Keyvan Heshmati, MD	Dr. Heshmati has nothing to disclose.
Wan Yee Kong, MBBS	Dr. Kong has nothing to disclose.
Jennifer A. Kim, MD	Dr. Kim has nothing to disclose.
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Mustafa Mohammed, MD, MBBS	Dr. Mohammed has nothing to disclose.
Cian Dabrowski, MS	Cian Dabrowski has nothing to disclose.
Shuvro Roy, MD	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Roy has received research support from The Siegel Rare Neuroimmune Association.
Houman Khosravani, MD, PhD	Dr. Khosravani has nothing to disclose.
Mohamed Fahmy Doheim	Mr. Doheim has nothing to disclose.
Antoinette M. Harrison, PharmD	Dr. Harrison has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Amercia.
Deborah L. Carver, MD	Dr. Carver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Andrea Hildebrand	The institution of Ms. Hildebrand has received research support from National MS Society.
David E. Kvarnberg, MD	Dr. Kvarnberg has nothing to disclose.
Andrew Ferree, MD, PhD	Dr. Ferree has nothing to disclose.
D Kevin Horton	No disclosure on file
Eduardo Arteaga Bracho	Eduardo Arteaga Bracho has nothing to disclose.
Shruthishree Sukumar	Shruthishree Sukumar has nothing to disclose.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Thomas E. Mullen, PhD	Dr. Mullen has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Mullen has received stock or an ownership interest from Quest Diagnostics.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Rebecca K. Miller-Kuhlmann, MD	Dr. Miller-Kuhlmann has nothing to disclose.
Matheus Alves A. Silva, MD	Dr. Silva has nothing to disclose.
Ying Liu	Ying Liu has nothing to disclose.
Isha Snehal, MBBS	Dr. Snehal has nothing to disclose.
Liliana Montoya, MD	Dr. Montoya has nothing to disclose.
Angelika Erwin	Angelika Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Han S. Lee	Mr. Lee has nothing to disclose.
Neha Gandhi, MD	Dr. Gandhi has nothing to disclose.
Temitope A. Lawal, MD	Dr. Lawal has nothing to disclose.
Aimalohi Esechie, MD, PhD	Dr. Esechie has nothing to disclose.
Michael L. Palm, MD, FAAN	Dr. Palm has received personal compensation in the range of $0-$499 for serving as a Member of the UCNS Accreditation Council with United Council for Neurologic Subspecialties.
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Zhenyuan Wang, PhD	Dr. Wang has nothing to disclose.
Melissa Reider-Demer, DNP, MN, CNP	Dr. Reider-Demer has nothing to disclose.
Shayan Torabi Moghaddam, DO	Dr. Torabi Moghaddam has nothing to disclose.
Laurie Wagner	Laurie Wagner has nothing to disclose.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Lubna E. El Sheikh, Jr., MBBS	Dr. El Sheikh has nothing to disclose.
Cedric Laloyaux, PhD	Dr. Laloyaux has received personal compensation for serving as an employee of UCB.
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
David B. Burkholder, MD, FAAN	The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
Christopher Seet, MBBS	Dr. Seet has nothing to disclose.
Nitin Butala, MD, FAAN	Dr. Butala has nothing to disclose.
Sara B. Mitchell, MD	Dr. Mitchell has nothing to disclose.
Rosario Maria S. Riel-Romero, MD, FAAN	Dr. Riel-Romero has stock in Biointech. Dr. Riel-Romero has stock in Intuitive Surgical. Dr. Riel-Romero has stock in CRISPR. Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with LSU. An immediate family member of Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Surgeon with VA.
Janardan S. Sivapalan	Mr. Sivapalan has nothing to disclose.
William Souza Martins Ferreira	Mr. Souza Martins Ferreira has nothing to disclose.
Junaid Ansari, MD	Dr. Ansari has nothing to disclose.
Alejandro Gonzalez Aquines, Sr.	Mr. Gonzalez Aquines has nothing to disclose.
Tina Duong	Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Yi Dai	No disclosure on file
Moon Han, PhD	Dr. Han has nothing to disclose.
Ondrej Dostal	The institution of Ondrej Dostal has received research support from Ministry of ��ɫ�� Youths and Sports.
Christopher J. Boes, MD, FAAN	Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to AAN interests or activities.
Sam Payabvash	Sam Payabvash has nothing to disclose.
Manuel Toledo	Manuel Toledo has nothing to disclose.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Carmen Serrano, MD, FAAN	The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Tamara Strohm, MD	Dr. Strohm has nothing to disclose.
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Morenikeji Komolafe, MD	Dr. Komolafe has nothing to disclose.
Daniel Zhou, MD	The institution of Dr. Zhou has received research support from American Epilepsy Society. The institution of Dr. Zhou has received research support from National Institutes of Health.
Tania Reyna, MD, FAAN	Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics .
Maria Diaz Ordonez, MD	The institution of Dr. Diaz Ordonez has received research support from Pfizer.
Jessica Falco-Walter, MD, FAAN	Dr. Falco-Walter has nothing to disclose.
Svetlana Blitshteyn, MD, FAAN	Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Blitshteyn has received publishing royalties from a publication relating to health care. Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Healthcare Expert with Agency for Healthcare Quality and Research, US Health and Human Services.
Anna Zolyan, MD	Dr. Zolyan has nothing to disclose.
Aaron Yarlas, PhD	Dr. Yarlas has received personal compensation for serving as an employee of Ionis Pharmaceuticals. Dr. Yarlas has stock in Ionis Pharmaceuticals.
Musab Ali, MD	Dr. Ali has nothing to disclose.
Maryum Shoukat, MD	Dr. Shoukat has nothing to disclose.
Osama M. Abu-hadid, MD	Dr. Abu-hadid has nothing to disclose.
Vasuki Dandu, MD	Dr. Dandu has nothing to disclose.
Hina N. Dave, MD	Dr. Dave has nothing to disclose.
Brandon M. Ghislain	Mr. Ghislain has nothing to disclose.
Satoru Morimoto	Satoru Morimoto has nothing to disclose.
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Pradeep Kumar Gunasekaran	No disclosure on file
Lindsay Rechtman	The institution of Lindsay Rechtman has received research support from ATSDR.
Basil T. Darras, MD	The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Paul Mehta	Paul Mehta has nothing to disclose.
Junaid H. Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Alejandra Garland Becerra, MD	Dr. Garland Becerra has nothing to disclose.
Emmanuel Jesus Escobar Valdivia, MD	Dr. Escobar Valdivia has nothing to disclose.
Vivekananda Datta	Vivekananda Datta has received personal compensation for serving as an employee of Quest Diagnostics.
Inna Keselman, MD, PhD	Dr. Keselman has nothing to disclose.
Eugenie Girouard, MD	Eugénie Girouard has nothing to disclose.
Sukanthi Kovvuru, MD	Dr. Kovvuru has nothing to disclose.
Frank Salamone	Mr. Salamone has nothing to disclose.
Nuran Dilek	Nuran Dilek has nothing to disclose.
Daniel Torres, MD	Dr. Torres has received publishing royalties from a publication relating to health care.
Aaisha Mozumder, MD	Dr. Mozumder has nothing to disclose.
Patrice LaLive, MD	Dr. LaLive has nothing to disclose.
Sinead Murphy	Sinead Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Sinead Murphy has received research support from Novartis.
Franca Cambi, MD	The institution of Dr. Cambi has received research support from NIH.
Samantha K. Holden, MD, MS, FAAN	The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Mayowa Owolabi, MD, FAAN	Dr. Owolabi has nothing to disclose.
Jessica Abreu Garcia, MD	Dr. Abreu Garcia has nothing to disclose.
Jennifer Jain, MD, BSc	Dr. Jain has nothing to disclose.
Deanna Saylor, MD, MHS	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from ��ɫ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and ��ɫ��al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Valeriya Levitan, MD	Dr. Levitan has nothing to disclose.
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Johnny A. Sanabria Lopez, MD	Dr. Sanabria Lopez has nothing to disclose.
Kavita M. Grover, MD, FAAN	Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Vincent H. Bargnes III	Mr. Bargnes has received research support from Harry Dent Family Foundation.
Mashina Chomba, MBChB	Dr. Chomba has nothing to disclose.
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
Harold J. Weinberg, MD	Dr. Weinberg has nothing to disclose.
Abolfazl Avan, MD, PhD	Dr. Avan has nothing to disclose.
Benedict R. Pereira, MD	Dr. Pereira has nothing to disclose.
Laurice T. Yang, MD, MHA, FAAN	The institution of Dr. Yang has received research support from Alzheimer's Disease Research Center (ADRC). The institution of Dr. Yang has received research support from Pacific Northwest Udall Center . The institution of Dr. Yang has received research support from Biogen/Parkinson's Study Group . The institution of Dr. Yang has received research support from Eli Lily . The institution of Dr. Yang has received research support from Michael J. Fox Foundation For Parkinson's Research . The institution of Dr. Yang has received research support from Sanofi . Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Chair, Workgroup with ��ɫ�� .
Marta Valente	No disclosure on file
Ali M. Al-Salahat, MBBS	Dr. Al-Salahat has nothing to disclose.
Carlos Santiago Claverie, MD	No disclosure on file
Casey J. Judge, DO	Dr. Judge has nothing to disclose.
Melody T. Asukile, MBBS	Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Kateryna Kurako, MD	Dr. Kurako has nothing to disclose.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Noelia C. Morales, MD	Dr. Morales has nothing to disclose.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Alison Herman	Ms. Herman has nothing to disclose.
Suman Siddamreddy	Suman Siddamreddy has nothing to disclose.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Srinivasa Rao Kundeti	Srinivasa Rao Kundeti has nothing to disclose.
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
Claire Ruane	Ms. Ruane has nothing to disclose.
Catherine Marti	No disclosure on file
Pojen Deng, MD	Dr. Deng has nothing to disclose.
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Jonathan Donnelly, MBBS	Dr. Donnelly has nothing to disclose.
John K. Lee, MD, PhD	Dr. Lee has nothing to disclose.
Franco E. Appiani, MD	Dr. Appiani has nothing to disclose.
Michael Isfort, MD	Dr. Isfort has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Ihedinachi Ndukwe, MD	Dr. Ndukwe has nothing to disclose.
Parisorn Thepmankorn	Ms. Thepmankorn has received personal compensation for serving as an employee of Johnson and Johnson.
Muhammad F. Bilal, MD, FAAN	Dr. Bilal has nothing to disclose.
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Sherri A. Braksick, MD, FAAN	Dr. Braksick has nothing to disclose.
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Ming Hui Yong, MD	Dr. Yong has nothing to disclose.
Megan G. Pino	Ms. Pino has nothing to disclose.
Adam B. Edwards, MD	Dr. Edwards has nothing to disclose.
Laura Mullen, MD	Ms. Mullen has nothing to disclose.
Miriam L. Freimer, MD, FAAN	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Matthew Purbaugh, MD	Dr. Purbaugh has nothing to disclose.
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Jeffrey Zhang	The institution of Jeffrey Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BioVie.
Duncan Brown	Duncan Brown has received personal compensation for serving as an employee of Akcea Therapeutics, Inc. Duncan Brown has received stock or an ownership interest from Akcea Therapeutics, Inc.
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Narges Moghimi, MD	Dr. Moghimi has nothing to disclose.
Christianne Mojica	Christianne Mojica has nothing to disclose.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Catherine Boldig, DO	Dr. Boldig has nothing to disclose.
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Michael B. Beeler, DO	Dr. Beeler has received personal compensation for serving as an employee of United States Navy.
Jason Massa, DO, FAAN	Dr. Massa has nothing to disclose.
David K. Chan, MD	Dr. Chan has nothing to disclose.
Habib Georges Moutran Barroso, MD	Dr. Moutran Barroso has nothing to disclose.
Mirela Cerghet, MD, PhD, FAAN	Dr. Cerghet has nothing to disclose.
Gary W. Clauser, MD	Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Yugaku Date, MD, PhD	Dr. Daté has nothing to disclose.
Anthony A. Hanna	Mr. Hanna has nothing to disclose.
Mataa Mataa, MD	Mataa Mataa has nothing to disclose.
Valeria A. Sansone, MD	Dr. Sansone has nothing to disclose.
Kalea L. Colletta, DO	Dr. Colletta has nothing to disclose.
Rufus O. Akinyemi, MD	Dr. Akinyemi has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Christopher McGuigan, MD	An immediate family member of Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. McGuigan has received research support from Novartis.
Ghazala Hayat, MBBS, FAAN	Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for kabafusion. Dr. Hayat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for csl. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Hayat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for MTPA. Dr. Hayat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Hayat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for kabafusion.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Benjamin Yong Qiang Tan	Benjamin Yong Qiang Tan has nothing to disclose.
Aaron E. Izenberg, MD	Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.
Chadi Darwich, MD	Dr. Darwich has nothing to disclose.
Robin L. Brey, MD	The institution of Dr. Brey has received research support from State of Texas. Dr. Brey has a non-compensated relationship as a Task Force Member with AAN that is relevant to AAN interests or activities.
Saad Karim, MD	Dr. Karim has nothing to disclose.
Christine C. Guo, PhD	No disclosure on file
Melissa Hagan	Melissa Hagan has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc..
Montserrat Vera Llonch	Montserrat Vera Llonch has received personal compensation for serving as an employee of Akcea. Montserrat Vera Llonch has received stock or an ownership interest from Akcea.
Andrew R. Snavely	Mr. Snavely has nothing to disclose.
Faizan Aslam, MBBS	Dr. Aslam has nothing to disclose.
Sydney V. Palka, MD	Dr. Palka has nothing to disclose.
Ladislav Pazdera, MD, FAAN	Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Justin Kinsella, MD	Dr. Kinsella has nothing to disclose.
Xiaowei W. Su, MD, PhD	The institution of Dr. Su has received research support from H. G. Barsumian, M.D. Memorial Fund.
Maxime Berube-Desrosiers, MD	Dr. Berube-Desrosiers has nothing to disclose.
David D. Adams	David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Leonard L. Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Emma Bowden	No disclosure on file
Anika Morgado	Ms. Morgado has nothing to disclose.
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Deborah Rose, MD	Dr. Rose has nothing to disclose.
Brian D. Moseley, MD	Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Hui Jin Chiew, MBBS	Dr. Chiew has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Carlos F. Martinez, MD	Dr. Martinez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen Cilag.
Aakashi Shah, MD	Dr. Shah has nothing to disclose.
Mariana Nelson, PhD	Dr. Nelson has received personal compensation for serving as an employee of AbbVie. Dr. Nelson has stock in AbbVie Inc.
Batool A. Hussain, MD, MBBS	Dr. Hussain has nothing to disclose.
Paul Wilkerson, DO	Dr. Wilkerson has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��